Latest Posts for Investor Relations
CSAM delivers 12% growth in 2022, posting record full-year revenue of NOK 370 million
Transactions carried out under the share buy-back program
Transactions carried out under the share buy-back program
Transactions carried out under the share buy-back programme
CSAM Health Group realises cost synergies to restore profitability levels
Announcement of launch of share buyback program
CSAM delivers growth in ARR and 5% EBITDA margin in Q3-22
Notice from Written Resolution/Bondholder Meeting
CSAM Health Group AS – Notice of written resolution of bondholders
CSAM Health Group AS: Minutes from Extraordinary General Meeting
CSAM Health Group AS – Notice of Extraordinary General Meeting
CSAM Health Group announces 13% growth for the second quarter of 2022
Launch of share buyback programme
CSAM Health Group AS: Minutes from the annual general meeting
